Why would they need to go out talking to brokers? They are funded through to commercialisation. So surely no need to get brokers interested as they won't need to raise capital any time soon? I'd expect them to be doing presentations to the medical community spreading awareness of the technology.
What i wan't to see is an update re timings for approval from the various regulating bodies, required trials, partners ect. This will ultimately dictate the value of the stock in the short term.
AGM, page-20
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
